ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 132 filers reported holding ENDOLOGIX INC in Q1 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,748,000 | -64.0% | 305,519 | -19.5% | 0.00% | -66.7% |
Q3 2016 | $4,861,000 | +3.8% | 379,750 | +1.0% | 0.01% | 0.0% |
Q2 2016 | $4,684,000 | +70.5% | 375,948 | +14.4% | 0.01% | +50.0% |
Q1 2016 | $2,748,000 | -13.0% | 328,656 | +3.0% | 0.00% | 0.0% |
Q4 2015 | $3,160,000 | -10.0% | 319,203 | +11.4% | 0.00% | -20.0% |
Q3 2015 | $3,513,000 | -12.3% | 286,528 | +9.7% | 0.01% | 0.0% |
Q2 2015 | $4,006,000 | +17.7% | 261,174 | +31.0% | 0.01% | +25.0% |
Q1 2015 | $3,403,000 | +27.6% | 199,336 | +14.3% | 0.00% | 0.0% |
Q4 2014 | $2,666,000 | +42.5% | 174,362 | -1.2% | 0.00% | +33.3% |
Q3 2014 | $1,871,000 | -29.9% | 176,510 | +0.5% | 0.00% | -25.0% |
Q2 2014 | $2,670,000 | +19.1% | 175,573 | +0.8% | 0.00% | +33.3% |
Q1 2014 | $2,242,000 | -25.5% | 174,214 | +0.9% | 0.00% | -25.0% |
Q4 2013 | $3,011,000 | +5.5% | 172,627 | -2.3% | 0.00% | -20.0% |
Q3 2013 | $2,853,000 | +29.7% | 176,780 | +6.7% | 0.01% | +25.0% |
Q2 2013 | $2,199,000 | – | 165,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |